US pharma giant Pfizer has criticized the recent inclusion of the company in the list of enterprises that should be denied ...

Artbio, a US biotech specializing in radiopharmaceuticals, has raised $132 million in a series B financing to move its lead ...

A major US trial has found that structured healthy lifestyle programs can slow memory loss in older adults, regardless of ...

Apellis Pharmaceuticals (Nasdaq: APLS) has received clearance from the American medicines regulator for Empaveli (pegcetacoplan) as the first treatment to reduce proteinuria in patients aged 12 and ...

A new real-world analysis from UK drugmaker Indivior (Nasdaq: INDV) suggests that patients with opioid use disorder (OUD) ...

Eli Lilly today announced positive top-line results from the Phase III BRUIN CLL-314 clinical trial of Jaypirca ...

Russia is currently experiencing a strong increase in the sales of drugs against alcoholism, as the number of citizens, who ...

Privately-held Italian pharma company Alfasigma has announced positive topline results from the OLINGUITO Phase III trial of ...

Family-owned Boehringer Ingelheim, now Germany’s largest drugmaker by revenue, has reported positive growth in the first half ...

US pharma giant Merck & Co was trading 4% lower in pre-market Tuesday after the group presented its second quarter 2025 ...

US pharma major Bristol Myers Squibb and Bain Capital announced the creation of a new independent biopharmaceutical company ...

US biotech PTC Therapeutics’ shares trading up 4.8% to $46.48 in after-hours activity yesterday, as it announced that the US ...